annual EBIT:
-$192.40M-$107.75M(-127.27%)Summary
- As of today (June 17, 2025), MLYS annual earnings before interest & taxes is -$192.40 million, with the most recent change of -$107.75 million (-127.27%) on December 31, 2024.
- During the last 3 years, MLYS annual EBIT has fallen by -$173.02 million (-892.74%).
- MLYS annual EBIT is now -5711.02% below its all-time high of -$3.31 million, reached on December 1, 2020.
Performance
MLYS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBIT:
-$44.45M+$7.32M(+14.14%)Summary
- As of today (June 17, 2025), MLYS quarterly earnings before interest & taxes is -$44.45 million, with the most recent change of +$7.32 million (+14.14%) on March 31, 2025.
- Over the past year, MLYS quarterly EBIT has dropped by -$9.09 million (-25.69%).
- MLYS quarterly EBIT is now -586.02% below its all-time high of -$6.48 million, reached on June 1, 2022.
Performance
MLYS quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$201.49M-$9.09M(-4.72%)Summary
- As of today (June 17, 2025), MLYS TTM earnings before interest & taxes is -$201.49 million, with the most recent change of -$9.09 million (-4.72%) on March 31, 2025.
- Over the past year, MLYS TTM EBIT has dropped by -$96.41 million (-91.75%).
- MLYS TTM EBIT is now -2744.67% below its all-time high of -$7.08 million, reached on December 1, 2021.
Performance
MLYS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
MLYS EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -127.3% | -25.7% | -91.8% |
| 3 y3 years | -892.7% | -487.2% | -1275.2% |
| 5 y5 years | -5711.0% | -527.5% | -2744.7% |
MLYS EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -892.7% | at low | -586.0% | +26.1% | -853.5% | at low |
| 5 y | 5-year | -5711.0% | at low | -586.0% | +26.1% | -2744.7% | at low |
| alltime | all time | -5711.0% | at low | -586.0% | +26.1% | -2744.7% | at low |
MLYS EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$44.45M(-14.1%) | -$201.49M(+4.7%) |
| Dec 2024 | -$192.40M(+127.3%) | -$51.77M(-13.9%) | -$192.40M(+14.3%) |
| Sep 2024 | - | -$60.11M(+33.1%) | -$168.35M(+25.2%) |
| Jun 2024 | - | -$45.17M(+27.7%) | -$134.51M(+28.0%) |
| Mar 2024 | - | -$35.36M(+27.6%) | -$105.08M(+24.1%) |
| Dec 2023 | -$84.66M | -$27.71M(+5.5%) | -$84.66M(+26.4%) |
| Sep 2023 | - | -$26.27M(+67.0%) | -$66.95M(+39.2%) |
| Jun 2023 | - | -$15.73M(+5.3%) | -$48.10M(+23.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$14.94M(+49.3%) | -$38.85M(+23.4%) |
| Dec 2022 | -$31.48M(+62.4%) | -$10.01M(+34.8%) | -$31.48M(+10.2%) |
| Sep 2022 | - | -$7.42M(+14.6%) | -$28.55M(+35.1%) |
| Jun 2022 | - | -$6.48M(-14.4%) | -$21.13M(+44.2%) |
| Mar 2022 | - | -$7.57M(+6.9%) | -$14.65M(+106.9%) |
| Dec 2021 | -$19.38M(+485.4%) | - | - |
| Dec 2021 | - | -$7.08M | -$7.08M |
| Dec 2020 | -$3.31M | - | - |
FAQ
- What is Mineralys Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual EBIT year-on-year change?
- What is Mineralys Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly EBIT year-on-year change?
- What is Mineralys Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Mineralys Therapeutics?
- What is Mineralys Therapeutics TTM EBIT year-on-year change?
What is Mineralys Therapeutics annual earnings before interest & taxes?
The current annual EBIT of MLYS is -$192.40M
What is the all time high annual EBIT for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual earnings before interest & taxes is -$3.31M
What is Mineralys Therapeutics annual EBIT year-on-year change?
Over the past year, MLYS annual earnings before interest & taxes has changed by -$107.75M (-127.27%)
What is Mineralys Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of MLYS is -$44.45M
What is the all time high quarterly EBIT for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly earnings before interest & taxes is -$6.48M
What is Mineralys Therapeutics quarterly EBIT year-on-year change?
Over the past year, MLYS quarterly earnings before interest & taxes has changed by -$9.09M (-25.69%)
What is Mineralys Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of MLYS is -$201.49M
What is the all time high TTM EBIT for Mineralys Therapeutics?
Mineralys Therapeutics all-time high TTM earnings before interest & taxes is -$7.08M
What is Mineralys Therapeutics TTM EBIT year-on-year change?
Over the past year, MLYS TTM earnings before interest & taxes has changed by -$96.41M (-91.75%)